Advertisement

Minn. Medical Marijuana Company Hit by Product Shortage

LeafLine Labs says unforeseen delays at the lab have caused it to temporarily scale back its business. LeafLine Labs says unforeseen delays at the lab have caused it to temporarily scale back its business. | 

November 29, 2017 10:19 AM

ST. PAUL, Minn. (AP) - One of Minnesota's two medical marijuana manufacturers is temporarily scaling back its business amid a shortage of medicine.

Advertisement – Content Continues Below

The shortage of medical marijuana at LeafLine Labs is causing problems for patients like Kellie Germann, who suffers from post-traumatic stress disorder. Germann tells WCCO-TV she'll have to go at least six days without medication that helps her eat, sleep and function.

LeafLine chief executive Andrew Bachman faults the shortage on "unforeseen delays at the lab," where state law requires medication to be tested before sale. The company is closing its Eagan dispensary, one of four it operates in the state, until at least Friday.

It's unclear how many patients are effected by the shortage. Bachman says the company is working to reschedule patients.

___

Information from: WCCO-TV


WDIO

Copyright 2017 The Associated Press. All rights reserved.

Advertisement
Advertisement
Relay Media Amp

Official: Device Explodes on NYC Subway Platform

Bentleyville Benefits Winter Tourism Economy in Duluth

Survey Finds Medications Accumulating in Minnesota Lakes

Governor Walker to Sign Bill Lifting Mining Moratorium

Parents Warned About Potential Dangerous Toys

Live Nativity Scene held in Duluth

Advertisement